ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
Spoke,
GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. “ProPhase” (NASDAQ: PRPH), a growth oriented and…
GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. “ProPhase” (NASDAQ: PRPH), a growth oriented and…
GlobeNewswire 2022-12-19 GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. “ProPhase” (NASDAQ: PRPH), a growth oriented and…
GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- “ProPhase” (NASDAQ: PRPH), a growth oriented and diversified diagnostics…